RSV Vaccine Development Study

Study title: The Development and Validation of Assays for RSV Vaccine Development

Age range: Healthy children under 1 year old

Study criteria: Healthy children who have not had and RSV infection

Contact email: ecc.vaccine@emory.edu

Contact Phone number: 404-727-4044

Study Description

The purpose of this study is to better understand how the body’s immune system responds to the Respiratory Syncytial Virus (RSV). RSV causes breathing problems and is one of the most common reasons that young children are hospitalized. 

Many people are trying to develop a vaccine to prevent RSV.  A good RSV vaccine could prevent 50,000 to 125,000 hospitalizations in the US alone.  A big problem with developing a vaccine is that current RSV blood tests often give the wrong answer in young children. A better blood test for RSV will help with the development of an RSV vaccine.  This study will help us to develop more accurate blood tests for RSV.

Who Can Participate?

Healthy children under 1 year old

What is involved?

The study involves 1 clinic visit at Emory Children’s Center with a small blood draw of up to 2.5 teaspoons.

What are the benefits?

This study is not designed to benefit you or your child directly. The results of this study may be helpful for other children in the future.

 This study is free. To say thank you, families will be compensated for their time and participation.